These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 7713475)

  • 21. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
    Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
    Adiels M; Olofsson SO; Taskinen MR; Borén J
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1225-36. PubMed ID: 18565848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dyslipidemia in diabetes mellitus].
    Niemeijer-Kanters SD; Banga JD; Erkelens DW
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):769-74. PubMed ID: 11346913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic dyslipidemia and atherosclerosis.
    Shepherd J
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1933-7. PubMed ID: 7973520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Insulin resistance and arterial hypertension].
    Weidmann P; Müller-Wieland D; de Courten M; Krone W
    Herz; 1995 Feb; 20(1):16-32. PubMed ID: 7713473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type II diabetes and syndrome X. Pathogenesis and glycemic management.
    Karam JH
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
    Yki-Järvinen H
    Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid metabolism in non-insulin-dependent diabetes mellitus: effect of glipizide therapy.
    Greenfield MS; Doberne L; Rosenthal M; Vreman HJ; Reaven GM
    Arch Intern Med; 1982 Aug; 142(8):1498-1500. PubMed ID: 7103631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of triglycerides in cardiovascular diseases].
    Bruckert E; Emmerich J; Delahaye F; Richard JL; Thomas D
    Arch Mal Coeur Vaiss; 1992 Oct; 85 Spec No 3():29-35. PubMed ID: 1296543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance and lipid metabolism.
    Howard BV
    Am J Cardiol; 1999 Jul; 84(1A):28J-32J. PubMed ID: 10418856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome as a cardiovascular risk factor.
    Krone W; Meinertz T
    Herz; 1995 Feb; 20(1):2-4. PubMed ID: 7713474
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolic and health complications of obesity.
    Grundy SM; Barnett JP
    Dis Mon; 1990 Dec; 36(12):641-731. PubMed ID: 2261844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoproteins, lipases, and the metabolic cardiovascular syndrome.
    Blomhoff JP
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S22-5. PubMed ID: 1283765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular mechanism of insulin resistance in hyperlipidemia].
    Murakami T; Yamada N
    Nihon Rinsho; 1999 Dec; 57(12):2657-61. PubMed ID: 10638192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Screening and therapy control of lipid metabolism disturbances in general practice (author's transl)].
    Assmann G; Schriewer H
    MMW Munch Med Wochenschr; 1980 Mar; 122(13):449-52. PubMed ID: 6769013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance in hypertension--a relationship with consequences?
    Berne C
    J Intern Med Suppl; 1991; 735():65-73. PubMed ID: 2043224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of abnormalities of carbohydrate and lipoprotein metabolism in the pathogenesis and clinical course of hypertension.
    Reaven GM
    J Cardiovasc Pharmacol; 1990; 15 Suppl 5():S4-7. PubMed ID: 1694930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.